Analysing breast cancer survivors’ acceptance profiles for using an electronic pillbox connected to a smartphone application using Seintinelles, a French community-based research tool

Introduction: Up to 50% of breast cancer (BC) survivors discontinue their adjuvant endocrine therapy (AET) before the recommended 5 years, raising the issue of medication non-adherence. eHealth technologies have the potential to support patients to enhance their medication adherence and may offer an...

Full description

Bibliographic Details
Main Authors: Catherine Goetzinger, Caroline Alleaume, Anna Schritz, Bernard Vrijens, Marie Préau, Guy Fagherazzi, Laetitia Huiart
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.889695/full
_version_ 1811204050717245440
author Catherine Goetzinger
Catherine Goetzinger
Caroline Alleaume
Anna Schritz
Bernard Vrijens
Marie Préau
Guy Fagherazzi
Guy Fagherazzi
Laetitia Huiart
author_facet Catherine Goetzinger
Catherine Goetzinger
Caroline Alleaume
Anna Schritz
Bernard Vrijens
Marie Préau
Guy Fagherazzi
Guy Fagherazzi
Laetitia Huiart
author_sort Catherine Goetzinger
collection DOAJ
description Introduction: Up to 50% of breast cancer (BC) survivors discontinue their adjuvant endocrine therapy (AET) before the recommended 5 years, raising the issue of medication non-adherence. eHealth technologies have the potential to support patients to enhance their medication adherence and may offer an effective way to complement the healthcare. In order for eHealth technologies to be successfully implemented into the healthcare system, end-users need to be willing and accepting to use these eHealth technologies.Aim: This study aims to evaluate the current usability of eHealth technologiesin and to identify differences in BC SURVIVORS BC survivors accepting a medication adherence enhancing eHealth technology to support their AET to BC survivors that do not accept such a medication adherence enhancing eHealth technology.Methods: This study was conducted in 2020 including volunteering BC survivors belonging to the Seintinelles Association. Eligible participants were women, diagnosed with BC within the last 10 years, and been exposed to, an AET. Univariable and multivariable logistic regression analyses were performed to investigate medication adherence enhancing eHealth technology acceptance profiles among BC survivors. The dependent variable was defined as acceptance of an electronic pillbox connected to a smartphone application (hereafter: medication adherence enhancing eHealth technology).Results: Overall, 23% of the participants already use a connected device or health application on a regular basis. The mean age of the participants was 52.7 (SD 10.4) years. In total, 67% of 1268 BC survivors who participated in the survey declared that they would accept a medication adherence enhancing eHealth technology to improve their AET. BC survivors accepting a medication adherence enhancing eHealth technology for their AET, are younger (OR = 0.97, 95% CI [0.95; 0.98]), do take medication for other diseases (OR = 0.31, 95% CI [0.13; 0.68]), already use a medication adherence enhancing eHealth technology or technique (OR = 1.74, 95% CI [1.06; 2.94]) and are willing to possess or currently possess one or more connected devices or health applications (OR = 2.89, 95% CI [2.01; 4.19]).Conclusion: Understanding acceptance profiles of BC survivors is fundamental for conceiving an effective eHealth technology enhancing AET among BC survivors. Hence, such profiling will foster the development of personalized medication adherence enhancing eHealth technology.
first_indexed 2024-04-12T03:06:18Z
format Article
id doaj.art-6c3495448e6c4b9fa73f5152c2ba3535
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-12T03:06:18Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-6c3495448e6c4b9fa73f5152c2ba35352022-12-22T03:50:30ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-09-011310.3389/fphar.2022.889695889695Analysing breast cancer survivors’ acceptance profiles for using an electronic pillbox connected to a smartphone application using Seintinelles, a French community-based research toolCatherine Goetzinger0Catherine Goetzinger1Caroline Alleaume2Anna Schritz3Bernard Vrijens4Marie Préau5Guy Fagherazzi6Guy Fagherazzi7Laetitia Huiart8Deep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, LuxembourgUniversity of Luxembourg, Faculty of Science, Technology and Medicine, Esch-sur-Alzette, LuxembourgSanté Publique France, Paris, FranceCompetence Center for Methodology and Statistics, Luxembourg Institute of Health, Strassen, LuxembourgAARDEX Group & Department of Public Health, Liège University, Liège, BelgiumInstitut de Psychologie, Université Lumière Lyon 2, Lyon, FranceDeep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, LuxembourgUniversity of Luxembourg, Faculty of Science, Technology and Medicine, Esch-sur-Alzette, LuxembourgSanté Publique France, Paris, FranceIntroduction: Up to 50% of breast cancer (BC) survivors discontinue their adjuvant endocrine therapy (AET) before the recommended 5 years, raising the issue of medication non-adherence. eHealth technologies have the potential to support patients to enhance their medication adherence and may offer an effective way to complement the healthcare. In order for eHealth technologies to be successfully implemented into the healthcare system, end-users need to be willing and accepting to use these eHealth technologies.Aim: This study aims to evaluate the current usability of eHealth technologiesin and to identify differences in BC SURVIVORS BC survivors accepting a medication adherence enhancing eHealth technology to support their AET to BC survivors that do not accept such a medication adherence enhancing eHealth technology.Methods: This study was conducted in 2020 including volunteering BC survivors belonging to the Seintinelles Association. Eligible participants were women, diagnosed with BC within the last 10 years, and been exposed to, an AET. Univariable and multivariable logistic regression analyses were performed to investigate medication adherence enhancing eHealth technology acceptance profiles among BC survivors. The dependent variable was defined as acceptance of an electronic pillbox connected to a smartphone application (hereafter: medication adherence enhancing eHealth technology).Results: Overall, 23% of the participants already use a connected device or health application on a regular basis. The mean age of the participants was 52.7 (SD 10.4) years. In total, 67% of 1268 BC survivors who participated in the survey declared that they would accept a medication adherence enhancing eHealth technology to improve their AET. BC survivors accepting a medication adherence enhancing eHealth technology for their AET, are younger (OR = 0.97, 95% CI [0.95; 0.98]), do take medication for other diseases (OR = 0.31, 95% CI [0.13; 0.68]), already use a medication adherence enhancing eHealth technology or technique (OR = 1.74, 95% CI [1.06; 2.94]) and are willing to possess or currently possess one or more connected devices or health applications (OR = 2.89, 95% CI [2.01; 4.19]).Conclusion: Understanding acceptance profiles of BC survivors is fundamental for conceiving an effective eHealth technology enhancing AET among BC survivors. Hence, such profiling will foster the development of personalized medication adherence enhancing eHealth technology.https://www.frontiersin.org/articles/10.3389/fphar.2022.889695/fullmedication adherencemedication adherence enhancing interventionseHealthbreast canceruser-centered designpatient adherence
spellingShingle Catherine Goetzinger
Catherine Goetzinger
Caroline Alleaume
Anna Schritz
Bernard Vrijens
Marie Préau
Guy Fagherazzi
Guy Fagherazzi
Laetitia Huiart
Analysing breast cancer survivors’ acceptance profiles for using an electronic pillbox connected to a smartphone application using Seintinelles, a French community-based research tool
Frontiers in Pharmacology
medication adherence
medication adherence enhancing interventions
eHealth
breast cancer
user-centered design
patient adherence
title Analysing breast cancer survivors’ acceptance profiles for using an electronic pillbox connected to a smartphone application using Seintinelles, a French community-based research tool
title_full Analysing breast cancer survivors’ acceptance profiles for using an electronic pillbox connected to a smartphone application using Seintinelles, a French community-based research tool
title_fullStr Analysing breast cancer survivors’ acceptance profiles for using an electronic pillbox connected to a smartphone application using Seintinelles, a French community-based research tool
title_full_unstemmed Analysing breast cancer survivors’ acceptance profiles for using an electronic pillbox connected to a smartphone application using Seintinelles, a French community-based research tool
title_short Analysing breast cancer survivors’ acceptance profiles for using an electronic pillbox connected to a smartphone application using Seintinelles, a French community-based research tool
title_sort analysing breast cancer survivors acceptance profiles for using an electronic pillbox connected to a smartphone application using seintinelles a french community based research tool
topic medication adherence
medication adherence enhancing interventions
eHealth
breast cancer
user-centered design
patient adherence
url https://www.frontiersin.org/articles/10.3389/fphar.2022.889695/full
work_keys_str_mv AT catherinegoetzinger analysingbreastcancersurvivorsacceptanceprofilesforusinganelectronicpillboxconnectedtoasmartphoneapplicationusingseintinellesafrenchcommunitybasedresearchtool
AT catherinegoetzinger analysingbreastcancersurvivorsacceptanceprofilesforusinganelectronicpillboxconnectedtoasmartphoneapplicationusingseintinellesafrenchcommunitybasedresearchtool
AT carolinealleaume analysingbreastcancersurvivorsacceptanceprofilesforusinganelectronicpillboxconnectedtoasmartphoneapplicationusingseintinellesafrenchcommunitybasedresearchtool
AT annaschritz analysingbreastcancersurvivorsacceptanceprofilesforusinganelectronicpillboxconnectedtoasmartphoneapplicationusingseintinellesafrenchcommunitybasedresearchtool
AT bernardvrijens analysingbreastcancersurvivorsacceptanceprofilesforusinganelectronicpillboxconnectedtoasmartphoneapplicationusingseintinellesafrenchcommunitybasedresearchtool
AT mariepreau analysingbreastcancersurvivorsacceptanceprofilesforusinganelectronicpillboxconnectedtoasmartphoneapplicationusingseintinellesafrenchcommunitybasedresearchtool
AT guyfagherazzi analysingbreastcancersurvivorsacceptanceprofilesforusinganelectronicpillboxconnectedtoasmartphoneapplicationusingseintinellesafrenchcommunitybasedresearchtool
AT guyfagherazzi analysingbreastcancersurvivorsacceptanceprofilesforusinganelectronicpillboxconnectedtoasmartphoneapplicationusingseintinellesafrenchcommunitybasedresearchtool
AT laetitiahuiart analysingbreastcancersurvivorsacceptanceprofilesforusinganelectronicpillboxconnectedtoasmartphoneapplicationusingseintinellesafrenchcommunitybasedresearchtool